Table: Modalis Therapeutics -Q1 group results

Modalis Therapeutics

13/05/2026 07:39

May 13 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2026        Mar 31, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Operating     loss 342 mln        loss 632 mln                  
  Recurring     loss 322 mln        loss 651 mln                  
  Net           loss 323 mln        loss 652 mln                  
  EPS           loss 3.64 yen       loss 9.02 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T